CAHIR
Reports & Resources
Features
AI & Digital Health In MedTech: Navigating the fDA Regulatory Landscape
Frameworks, Compliance Strategies, and Competitive Differentiators for AI/ML Enabled Medical Devices
This report synthesizes the most consequential regulatory developments affecting AI-driven MedTech, drawing on perspectives from regulatory strategy, FDA engagement, industry product leadership, and risk and compliance disciplines. It is designed for senior MedTech executives, investors, innovators, and digital health leaders who require actionable intelligence on how the FDA’s evolving AI frameworks will shape innovation, regulatory risk, and competitive advantage.
Central Thesis: The FDA’s regulatory posture has shifted from static, one-time device approvals to a Total Product Lifecycle (TPLC) oversight model for AI-enabled devices. Companies that embed lifecycle thinking into their design, quality, and regulatory systems now will capture first-mover advantages in market access, FDA engagement, and stakeholder trust.
Report length: 17 pages / 20+ cited sources
Features
Predetermined Change Control Plans (PCCPs)
A Comprehensive Readiness Checklist for AI-Enabled Medical Device Manufacturers
A PCCP includes three core components: (1) Description of Modifications — what changes will be made; (2) Modification Protocol — how changes will be developed, validated, and implemented; and (3) Impact Assessment — the evaluation of benefits and risks. Each modification described in the PCCP must maintain the device’s intended use and provide reasonable assurance of continued safety and effectiveness.
This checklist is designed for MedTech executives, regulatory affairs professionals, quality engineers, and AI/ML
development teams preparing to develop or include a PCCP in a marketing submission. Use it to systematically
assess your organization’s readiness across every dimension of PCCP development and compliance.
Features
AI & U.S. Special Operations Command
How is SOCOM adapting AI for enhancements in operations, business enterprise and acquisitions?
